Skip to main content
CMMB
NASDAQ Life Sciences

Scipher Discloses 10.4% Chemomab Stake After $1.1M Note-Funded ADS Purchase

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.345
Mkt Cap
$9.492M
52W Low
$0.92
52W High
$2.99
52W Position info
46% above low
Off High info
55% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CMMB sits 46% above its 52-week low of $0.92.

Summary

Scipher reported a 10.4% stake in Chemomab after buying 932,203 ADSs at $1.18 for about $1.1M — a purchase required by the merger agreement and funded largely by $858,612 of Scipher's own convertible notes.


Key Events · Ownership and Investor Activity · CMMB

  • Scipher Reports 10.4% Chemomab Stake

    Scipher Medicine beneficially owns 74,576,240 ordinary shares (932,203 ADSs), or approximately 10.4% of the 643,889,200 shares outstanding as of October 29, 2026.

  • $1.1M Purchase Funded by Scipher Notes

    Scipher paid about $1.1M ($1.18 per ADS) using $858,612 of proceeds from October Notes sold to seven investors plus roughly $241,387 of working capital.

  • Notes Convert at Merger Closing

    The Notes mature August 5, 2027 and are satisfied at closing with Chemomab Parent shares equal to principal divided by $1.18, times the Domestication Exchange Ratio; if the merger terminates, the Notes stay outstanding and Scipher keeps the ADSs.

  • Purchase Was Contractually Required

    Section 5.6 of the July 7, 2026 merger agreement obligated Scipher to fund up to $1.1M after Chemomab's October 11 financing notice; Chemomab consented to the bridge notes on November 3.


Analysis · CMMB · Life Sciences

Scipher, the merger counterparty, now holds 74,576,240 Chemomab ordinary shares (932,203 ADSs) — a 10.4% stake — bought at $1.18 per ADS on November 3. The purchase was contractually required: Section 5.6 of the July 7 merger agreement obliges Scipher to fund up to $1.1M if Chemomab needs cash before closing, and Chemomab delivered a $1.1M financing notice on October 11. Scipher raised $858,612 of the price by issuing October Notes to its own investors and covered the rest from working capital. The stake is effectively escrowed for those noteholders: at closing, the Notes are cancelled in exchange for the Chemomab Parent shares and CVRs generated by the ADSs. If the merger terminates, the Notes stay outstanding and Scipher keeps the ADSs. The practical read is that the acquirer is financing the target's runway, and the 10.4% block is committed merger consideration rather than open-market conviction. The December 4 special meeting vote remains the gating event.

How filings like this one have moved

In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CMMB was trading at $1.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.5M. The 52-week trading range was $0.92 to $2.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CMMB - Latest Insights

CMMB
Nov 10, 2026, 5:26 PM EST
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $1.35 info
Change: $0 (0%) info
Market Cap: $9.492M info
CMMB
Oct 30, 2026, 4:32 PM EDT
Filing Type: DEFM14A
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $1.35 info
Change: +$0.225 (+20%) info
Market Cap: $9.492M info
CMMB
Oct 19, 2026, 5:28 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $1.35 info
Change: +$0.155 (+13%) info
Market Cap: $9.492M info
CMMB
Sep 30, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.19
Real-time Price: $1.35 info
Change: +$0.155 (+13%) info
Market Cap: $9.492M info
CMMB
Sep 25, 2026, 5:28 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $2.17
Real-time Price: $1.35 info
Change: -$0.8248 (-38%) info
Market Cap: $9.492M info